4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-024600
Options or other derivatives
- Interim Chief Medical Officer acquired 31,360 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Minev Boris Radoslavov Interim Chief Medical Officer | 2024-06-17 | Grant or award · Stock Options (right to buy) | +31,360 | 31,360 | D | ||
Loading xslF345X05/ownership.xml…